IT Solutions
Molecular marker could predict tumor progression
Jan 24 2012
A team of scientists from the University of California, San Francisco (UCSF) have developed a method that can predict tumour progression by tracking a molecular marker in tissue samples.
The molecular marker has been linked with better survival rates, and closely monitoring the marker could provide a more effective way for doctors to track their patients' recovery after surgery. This can determine how aggressive the follow-up treatment will be.
The chemical, called 2-HG, is linked to mutations in a gene known as IDH1, which is common in low-grade tumours and linked with higher survival rates. It has been found that over 70 per cent of patients with low-grade gliomas have mutations to the IDH1 genes in their cancer cells.
The technique has not yet been optimised for every-day use in the clinic, although it provides useful insights for doctors to gauge cancer recurrence.
According to Sarah Nelson, PhD, of the Department of Radiology and Biomedical Imaging, the study will now move to "developing methods to obtain images in a clinical setting".
Posted by Neil Clark
Digital Edition
International Labmate Buyers' Guide 2024/25
June 2024
Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...
View all digital editions
Events
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia